Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Hygieia Health's GlucosaGreen® Glucosamine Shows Substantial Equivalency in Ireland
Hygieia Health Co. Ltd has announced that the FSAI (Food Safety Authority of Ireland) has determined that GlucosaGreen® glucosamine is substantially equivalent to current glucosamine on the market. This substantial equivalency indicates that GlucosaGreen® glucosamine has been demonstrated to be safe in composition, nutritional value, metabolism, intended use and undesirable substance levels.
- Hygieia Health's GlucosaGreen® Glucosamine Shows Substantial Equivalency in Ireland
Hygieia Health Co. Ltd has announced that the FSAI (Food Safety Authority of Ireland) has determined that GlucosaGreen® glucosamine is substantially equivalent to current glucosamine on the market. This substantial equivalency indicates that GlucosaGreen® glucosamine has been demonstrated to be safe in composition, nutritional value, metabolism, intended use and undesirable substance levels.
- Hygieia Health's GlucosaGreen® Glucosamine Shows Substantial Equivalency in Ireland
Hygieia Health Co. Ltd has announced that the FSAI (Food Safety Authority of Ireland) has determined that GlucosaGreen® glucosamine is substantially equivalent to current glucosamine on the market. This substantial equivalency indicates that GlucosaGreen® glucosamine has been demonstrated to be safe in composition, nutritional value, metabolism, intended use and undesirable substance levels.
- Hygieia Health's GlucosaGreen® Glucosamine Shows Substantial Equivalency in Ireland
Hygieia Health Co. Ltd has announced that the FSAI (Food Safety Authority of Ireland) has determined that GlucosaGreen® glucosamine is substantially equivalent to current glucosamine on the market. This substantial equivalency indicates that GlucosaGreen® glucosamine has been demonstrated to be safe in composition, nutritional value, metabolism, intended use and undesirable substance levels.
- Hygieia Health's GlucosaGreen® Glucosamine Shows Substantial Equivalency in Ireland
Hygieia Health Co. Ltd has announced that the FSAI (Food Safety Authority of Ireland) has determined that GlucosaGreen® glucosamine is substantially equivalent to current glucosamine on the market. This substantial equivalency indicates that GlucosaGreen® glucosamine has been demonstrated to be safe in composition, nutritional value, metabolism, intended use and undesirable substance levels.
- Hygieia Health's GlucosaGreen® Glucosamine Shows Substantial Equivalency in Ireland
Hygieia Health Co. Ltd has announced that the FSAI (Food Safety Authority of Ireland) has determined that GlucosaGreen® glucosamine is substantially equivalent to current glucosamine on the market. This substantial equivalency indicates that GlucosaGreen® glucosamine has been demonstrated to be safe in composition, nutritional value, metabolism, intended use and undesirable substance levels.
- EAS gives regulatory crash course on food supplements
International food and nutrition policy consultancy EAS will hold a one-day intensive workshop, titled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch’, October 9 in Brussels, to help companies develop strategic solutions for launching food supplements in Europe’s diverse marketplace.
- EAS gives regulatory crash course on food supplements
International food and nutrition policy consultancy EAS will hold a one-day intensive workshop, titled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch’, October 9 in Brussels, to help companies develop strategic solutions for launching food supplements in Europe’s diverse marketplace.
- EAS gives regulatory crash course on food supplements
International food and nutrition policy consultancy EAS will hold a one-day intensive workshop, titled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch’, October 9 in Brussels, to help companies develop strategic solutions for launching food supplements in Europe’s diverse marketplace.
- EAS gives regulatory crash course on food supplements
International food and nutrition policy consultancy EAS will hold a one-day intensive workshop, titled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch’, October 9 in Brussels, to help companies develop strategic solutions for launching food supplements in Europe’s diverse marketplace.
- Discussion Forum provides platform for industry to debate regulatory challenges
The pros and cons of the European Union’s steps towards finalising significant new regulations will be on debate at next month’s Vitafoods International Discussion Forum in Geneva. This year’s panellists will include Bas van Buijtenen, Vice President Europe, Middle East, Africa Human Nutrition and Health at DSM Nutritional Products Europe Ltd; Hartwig Sievers from the management board of Phytolab, the research centre for German plant extracts group Martin Bauer; Gert Krabichler, Chairman of European trade organisation, the European Responsible Nutrition Alliance (ERNA); and Simon Pettman, Director of international food and nutrition policy consultancy EAS.
- Discussion Forum provides platform for industry to debate regulatory challenges
The pros and cons of the European Union’s steps towards finalising significant new regulations will be on debate at next month’s Vitafoods International Discussion Forum in Geneva. This year’s panellists will include Bas van Buijtenen, Vice President Europe, Middle East, Africa Human Nutrition and Health at DSM Nutritional Products Europe Ltd; Hartwig Sievers from the management board of Phytolab, the research centre for German plant extracts group Martin Bauer; Gert Krabichler, Chairman of European trade organisation, the European Responsible Nutrition Alliance (ERNA); and Simon Pettman, Director of international food and nutrition policy consultancy EAS.
- Discussion Forum provides platform for industry to debate regulatory challenges
The pros and cons of the European Union’s steps towards finalising significant new regulations will be on debate at next month’s Vitafoods International Discussion Forum in Geneva. This year’s panellists will include Bas van Buijtenen, Vice President Europe, Middle East, Africa Human Nutrition and Health at DSM Nutritional Products Europe Ltd; Hartwig Sievers from the management board of Phytolab, the research centre for German plant extracts group Martin Bauer; Gert Krabichler, Chairman of European trade organisation, the European Responsible Nutrition Alliance (ERNA); and Simon Pettman, Director of international food and nutrition policy consultancy EAS.
- Discussion Forum provides platform for industry to debate regulatory challenges
The pros and cons of the European Union’s steps towards finalising significant new regulations will be on debate at next month’s Vitafoods International Discussion Forum in Geneva. This year’s panellists will include Bas van Buijtenen, Vice President Europe, Middle East, Africa Human Nutrition and Health at DSM Nutritional Products Europe Ltd; Hartwig Sievers from the management board of Phytolab, the research centre for German plant extracts group Martin Bauer; Gert Krabichler, Chairman of European trade organisation, the European Responsible Nutrition Alliance (ERNA); and Simon Pettman, Director of international food and nutrition policy consultancy EAS.
- EU Regulatory developments could play role in defining international trends
Europe is fast becoming the world’s leading exporter of regulation as authorities in many countries increasingly look for models on which to base their legislation, Simon Pettman, Director of international food and nutrition policy consultancy EAS, has said.
- EU Regulatory developments could play role in defining international trends
Europe is fast becoming the world’s leading exporter of regulation as authorities in many countries increasingly look for models on which to base their legislation, Simon Pettman, Director of international food and nutrition policy consultancy EAS, has said.
- EU Regulatory developments could play role in defining international trends
Europe is fast becoming the world’s leading exporter of regulation as authorities in many countries increasingly look for models on which to base their legislation, Simon Pettman, Director of international food and nutrition policy consultancy EAS, has said.
- EU Regulatory developments could play role in defining international trends
Europe is fast becoming the world’s leading exporter of regulation as authorities in many countries increasingly look for models on which to base their legislation, Simon Pettman, Director of international food and nutrition policy consultancy EAS, has said.
- EU Regulatory developments could play role in defining international trends
Europe is fast becoming the world’s leading exporter of regulation as authorities in many countries increasingly look for models on which to base their legislation, Simon Pettman, Director of international food and nutrition policy consultancy EAS, has said.
- IADSA celebrates decade of global regulatory achievements
The International Alliance of Dietary/Food Supplement Associations (IADSA) this year celebrates ten years of helping to shape policies and regulations on dietary supplements across the globe.
- IADSA celebrates decade of global regulatory achievements
The International Alliance of Dietary/Food Supplement Associations (IADSA) this year celebrates ten years of helping to shape policies and regulations on dietary supplements across the globe.
- IADSA celebrates decade of global regulatory achievements
The International Alliance of Dietary/Food Supplement Associations (IADSA) this year celebrates ten years of helping to shape policies and regulations on dietary supplements across the globe.
- IADSA celebrates decade of global regulatory achievements
The International Alliance of Dietary/Food Supplement Associations (IADSA) this year celebrates ten years of helping to shape policies and regulations on dietary supplements across the globe.
- IADSA celebrates decade of global regulatory achievements
The International Alliance of Dietary/Food Supplement Associations (IADSA) this year celebrates ten years of helping to shape policies and regulations on dietary supplements across the globe.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- First assessment of Cognis Tonalin® CLA in EU Novel Food authorisation process completed
Cognis has announced that the Spanish authority for Food Safety and Nutrition (AESAN) has finalized its assessment of Tonalin® in the EU’s Novel Food authorisation process, following the company’s submission of a comprehensive dossier on its leading Tonalin® CLA brand in 2007.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- Novel food catalogue clarity reassuring but concerns remain says EHPM
European trade organisation EHPM has said it is ‘reassured’ by a statement from the European Commission that its recently published novel food catalogue is not legally binding for EU Member States, but has held concerns that listing an ingredient in the catalogue could prejudice its members’ products commercial viability because it may in practice be considered by some national authorities as a novel food ingredient.
- EAS Gives Regulatory Crash Course
International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels.
- EAS Gives Regulatory Crash Course
International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels.
- EAS Gives Regulatory Crash Course
International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels.
- EAS Gives Regulatory Crash Course
International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels.
- EAS Gives Regulatory Crash Course
International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels.
- EAS Gives Regulatory Crash Course
International food and nutrition policy consultancy EAS will be hosting a workshop entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch,’ October 9th, in Brussels.
- Health claims based only on human intervention studies not practical says IADSA
Commenting on the latest draft Codex Alimentarius recommendations for the scientific basis of health claims, IADSA said that while the clinical trial model is one source of scientific data, it is not practical when applied to the reduction of risk of disease in persons generally regarded as ‘healthy’.
- Health claims based only on human intervention studies not practical says IADSA
Commenting on the latest draft Codex Alimentarius recommendations for the scientific basis of health claims, IADSA said that while the clinical trial model is one source of scientific data, it is not practical when applied to the reduction of risk of disease in persons generally regarded as ‘healthy’.
- Health claims based only on human intervention studies not practical says IADSA
Commenting on the latest draft Codex Alimentarius recommendations for the scientific basis of health claims, IADSA said that while the clinical trial model is one source of scientific data, it is not practical when applied to the reduction of risk of disease in persons generally regarded as ‘healthy’.
- Health claims based only on human intervention studies not practical says IADSA
Commenting on the latest draft Codex Alimentarius recommendations for the scientific basis of health claims, IADSA said that while the clinical trial model is one source of scientific data, it is not practical when applied to the reduction of risk of disease in persons generally regarded as ‘healthy’.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- EFSA Adopts First Opinions on Health Claims Made on Foods Relating to Disease Risk Reduction and Children's Health
EFSA’s Panel on dietetic products, nutrition and allergies (NDA) has adopted its first series of opinions on claims referring to the reduction of disease risk, and children's development and health. Scientists of the NDA Panel examined the scientific evidence for 8 claims, 5 of which related to children’s health and 3 to disease risk reduction.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
This new approval confirms the integrity and quality of the ingredients Algatechnologies supplies to the dietary supplement and cosmeceuticals industries. It demonstrates Algatechnologies’ commitment to the highest standards of purity, quality and product safety in the industry.
“Our target is to maintain and enhance our leading position in the astaxanthin European market by providing ingredients of the highest quality and purity,” says Efrat Kat, Marketing Manager at Algatechnologies. “We continue to employ strictly controlled manufacturing operations and quality-assurance controls in our facilities. We will constantly increase our distribution network in Europe, as it is a major market for astaxanthin as demonstrated by a growth rate in double-digits over the last few years"
The market size of astaxanthin for human use is currently valued at around (€14-19M) and is forecast to experience significant growth over the next few years, driven by the increase in awareness of its health benefits.
Algatechnologies, a leading supplier of natural astaxanthin produced from Haematococcus pluvialis microalgae is located in Israel's Arava desert -- an optimal location for algae cultivation due to the stable climate conditions in the area and year-round high light intensities. “Producing the microalgae in a closed system and using sunlight as the energy source, allows us to offer an extremely pure product with the highest astaxanthin level. Our products are pesticide-free and allergen-free, and offered at competitive prices," adds Ms. Kat.
The company employs high pressure Super Critical CO2 extraction technology in order to produce 10% astaxanthin in an oleoresin form. This technology does not require the use of organic solvents and therefore the product does not contain any solvents residues.
Algatechnologies holds a world patent for its closed, environmentally protected cultivation system, allowing the production of a pure AstaPure®, astaxanthin product without biological or chemical contamination. Algatechnologies holds ISO 9001/2000, HACCP and GMP (for food) international accreditations.
Astaxanthin is a very potent antioxidant, recognized to be about 500 times more effective than vitamin E and much more powerful than other carotenoids, such as lutein, lycopene and beta-carotene. Astaxanthin supports a number of health conditions including eye health, skin health and health disorders related to the Central Nervous System (CNS).
For further information, please contact:
Ms.Efrat Kat
Marketing Manager
Algatechnologies Ltd.
Phone: +972-8-6356425
Mobile: +972-52-4599528
e-mail: efratk@algatech.com |